Retension Pharmaceuticals, Inc. (RTSN)
10.69
-0.03
(-0.28%)
USD |
NASDAQ |
Nov 06, 10:17
Retension Pharmaceuticals Total Liabilities (Quarterly) : 31.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.05M |
| Date | Value |
|---|---|
| March 31, 2026 | 29.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 152.22B |
| Abeona Therapeutics, Inc. | 51.45M |
| America Great Health | 5.048M |
| Acumen Pharmaceuticals, Inc. | 50.96M |
| Aardvark Therapeutics, Inc. | 6.663M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.13M |
| Shareholders Equity (Quarterly) | -14.92M |
| Debt to Equity Ratio | -1.888 |
| Current Ratio | 5.609 |